Abstract
There is increasing interest in using individually linked, routinely-collected healthcare systems data for Randomised Controlled Trials (RCTs). These “data-enabled” trials aim to reduce site and participant burden and increase efficiency of trial delivery.1 Routinely-collected data have been used successfully in large ‘big data’ retrospective studies for years,2 and new methodology such as target trial emulation has allowed researchers to reduce the bias inherent to retrospective data.3 This still cannot replace the traditional randomised trial design, but a hybrid approach potentially builds on the strengths of both designs.
| Original language | English |
|---|---|
| Pages (from-to) | 416-417 |
| Number of pages | 2 |
| Journal | European Journal of Vascular and Endovascular Surgery |
| Volume | 68 |
| Issue number | 3 |
| Early online date | 10 May 2024 |
| DOIs | |
| Publication status | E-pub ahead of print - 10 May 2024 |